In animal models, GLP-1RAs inhibited myocardial fibrosis and reduced ventricular hypertrophy
Sources Explore all treatments to support your metabolic health Get started for as little as $149 a month* $299/mo thereafter Get started for as little as $74 a month* $149/mo thereafter $1,498/mo $1,839/mo *Our starter program is only available for patients starting on the lowest dosage available
Discover the research Description AHK-Cu is a copper peptide designed for topical application
For individuals with disrupted sleep patterns related to aging, shift work, or chronic stress, Epithalon offers a mechanism-based approach to restoring healthy circadian biology
In the SURPASS-2 trial, tirzepatide 15 mg was superior to semaglutide 1 mg for HbA1c reduction, with up to 46% of patients achieving near-normoglycemia (HbA1c below 5.7%)